Search
Returning search results with filters:
Remove filter for
Audience: General public
Remove filter for
Recall class: Type I
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 15 of 90 items.
ATROPINE SULFATE INJECTION USP: Affected lot may contain the presence of glass particulate.
Affected lot may contain the presence of glass particulate.
RecallHealth product recall | 2023-09-20
Allergenic Extract Non Pollens: False negative for skin test
Affected lot may result in a false negative for skin test (pecan nut allergy)
RecallHealth product recall | 2023-09-07
Stiff Rock: Affected lots may contain the undeclared ingredients sildenafil and tadalafil
Affected lots may contain the undeclared ingredients sildenafil and tadalafil.
RecallHealth product recall | 2023-08-23
Pink Unicorn: Affected lots may contain the undeclared ingredient sildenafil (updated risk classification and reason for recall)
Affected lots may contain the undeclared ingredient sildenafil.
RecallHealth product recall | 2023-08-22
PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg: NDMA and NNORT impurity
Affected lots exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT) or exceed the acceptable cumulative intake limit for (N-nitrosodimethylamine (NDMA) and NNORT).
RecallHealth product recall | 2023-08-16
AMITRIPTYLINE 10 & 50mg: NDMA and NNORT impurity
Affected lot exceed the acceptable cumulative intake limit for N-nitrosodimethylamine (NDMA) and N-nitroso-nortriptyline (NNORT).
RecallHealth product recall | 2023-08-16
Apo-Acyclovir Tablets: NDMA impurity (Updated with new product and lot numbers)
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA).
RecallHealth product recall | 2023-08-14
APO-AMITRIPTYLINE Tablets: NNORT impurity
Affected lots exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT).
RecallHealth product recall | 2023-08-14
Elavil 25 mg: NNORT Impurity
Affected lots exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT).
RecallHealth product recall | 2023-08-14
Rhino 25: Affected lots may contain the undeclared ingredient yohimbe
Affected lots may contain the undeclared ingredient yohimbe.
RecallHealth product recall | 2023-08-10
Jaguar: Affected lots may contain the undeclared ingredient tadalafil
Affected lots may contain the undeclared ingredient tadalafil.
RecallHealth product recall | 2023-08-10
BANG: Affected lots may contain the undeclared ingredient sildenafil
Affected lots may contain the undeclared ingredient sildenafil.
RecallHealth product recall | 2023-08-10
Shiva Gold: Affected lots may contain the undeclared ingredients sildenafil and tadalafil
Affected lots may contain the undeclared ingredients sildenafil and tadalafil
RecallHealth product recall | 2023-08-10
Rush Hour Plus: Affected lots may contain the undeclared ingredient tadalafil
Affected lots may contain the undeclared ingredient tadalafil.
RecallHealth product recall | 2023-08-10
Ginseng Red: Affected lots may contain the undeclared ingredient sildenafil
Affected lots may contain the undeclared ingredient sildenafil.
RecallHealth product recall | 2023-08-10